Evidence map›Paper›PMID 34794445›Full record

ArticleMalaria journal2021

Red blood cell blood group A antigen level affects the ability of heparin and PfEMP1 antibodies to disrupt Plasmodium falciparum rosettes.

Pontus Hedberg, Madle Sirel, Kirsten Moll, Mpungu Steven Kiwuwa, Petter Höglund, Ulf Ribacke, Mats Wahlgren

Open access · goldAbstract read
In one paragraph

Article in Malaria journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Pontus HedbergDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-3153-098X
Madle SirelDepartment of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.
Kirsten MollDepartment of Medicine, Huddinge, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Mpungu Steven KiwuwaDepartment of Child Health and Development Centre, School of Medicine, Makerere University College of Health Sciences, Kampala, Uganda.
Petter HöglundDepartment of Medicine, Huddinge, Karolinska University Hospital, 141 86, Stockholm, Sweden.
Ulf Ribacke *Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden.
Mats Wahlgren *Department of Microbiology, Tumor and Cell Biology (MTC), Karolinska Institutet, 171 65, Stockholm, Sweden. Mats.wahlgren@ki.se.
Karolinska Institutet · SEKarolinska University Hospital · SEMakerere University · UG

Funding

Knut och Alice Wallenbergs Stiftelse KAW 2017.0055Stiftelsen för Strategisk Forskning SB12-0026Vetenskapsrådet VR 2016-02917Vetenskapsrådet VR 2018-05814
6 · The paper itself

Abstract

backgroundThe histo-blood group ABO system has been associated with adverse outcomes in COVID-19, thromboembolic diseases and Plasmodium falciparum malaria. An integral part of the severe malaria pathogenesis is rosetting, the adherence of parasite infected red blood cells (RBCs) to uninfected RBCs. Rosetting is influenced by the host's ABO blood group (Bg) and rosettes formed in BgA have previously been shown to be more resilient to disruption by heparin and shield the parasite derived surface antigens from antibodies. However, data on rosetting in weak BgA subgroups is scarce and based on investigations of relatively few donors.

methodsAn improved high-throughput flow cytometric assay was employed to investigate rosetting characteristics in an extensive panel of RBC donor samples of all four major ABO Bgs, as well as low BgA expressing samples.

resultsAll non-O Bgs shield the parasite surface antigens from strain-specific antibodies towards P. falciparum erythrocyte membrane protein 1 (PfEMP1). A positive correlation between A-antigen levels on RBCs and rosette tightness was observed, protecting the rosettes from heparin- and antibody-mediated disruption.

conclusionsThese results provide new insights into how the ABO Bg system affects the disease outcome and cautions against interpreting the results from the heterogeneous BgA phenotype as a single group in epidemiological and experimental studies.

Indexed as

Rosette FormationABO Blood-Group SystemAntibodies, ProtozoanFlow CytometryGene FrequencyHeparinHuman Genome ProjectHumansProtozoan ProteinsABO Blood-Group SystemAntibodies, Protozoanerythrocyte membrane protein 1, Plasmodium falciparumHeparinProtozoan ProteinsHisto-blood group ABO systemMalariaPlasmodium falciparumRosetting

Identifiers

PMID34794445
PMCPMC8600353
OpenAlexW3212675715

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.